Literature DB >> 18490932

B cell survival: an unexpected mechanism of lymphocyte vitality.

Micah J Benson1, Raul Elgueta, Randolph J Noelle.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18490932      PMCID： PMC3821797          DOI： 10.1038/icb.2008.35

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  13 in total

Review 1.  BAFF AND APRIL: a tutorial on B cell survival.

Authors:  Fabienne Mackay; Pascal Schneider; Paul Rennert; Jeffrey Browning
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.

Authors:  J A Gross; S R Dillon; S Mudri; J Johnston; A Littau; R Roque; M Rixon; O Schou; K P Foley; H Haugen; S McMillen; K Waggie; R W Schreckhise; K Shoemaker; T Vu; M Moore; A Grossman; C H Clegg
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

3.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

4.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

Authors:  Adrian P Grech; Michelle Amesbury; Tyani Chan; Sandra Gardam; Antony Basten; Robert Brink
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

5.  MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.

Authors:  N L Malinin; M P Boldin; A V Kovalenko; D Wallach
Journal:  Nature       Date:  1997-02-06       Impact factor: 49.962

6.  An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.

Authors:  Matthew D Morrison; William Reiley; Minying Zhang; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

7.  Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.

Authors:  Gongxian Liao; Minying Zhang; Edward W Harhaj; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

8.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Authors:  Sandra Gardam; Frederic Sierro; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2008-02-28       Impact factor: 31.745

9.  Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture.

Authors:  G Franzoso; L Carlson; L Poljak; E W Shores; S Epstein; A Leonardi; A Grinberg; T Tran; T Scharton-Kersten; M Anver; P Love; K Brown; U Siebenlist
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

10.  Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses.

Authors:  J H Caamaño; C A Rizzo; S K Durham; D S Barton; C Raventós-Suárez; C M Snapper; R Bravo
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307
View more
  2 in total

1.  The activation of BAFF/APRIL system in spleen and lymph nodes of Plasmodium falciparum infected patients.

Authors:  Wilanee Dechkhajorn; Surachet Benjathummarak; Supattra Glaharn; Urai Chaisri; Parnpen Viriyavejakul; Yaowapa Maneerat
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

2.  BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.

Authors:  Vassiliki Pelekanou; George Notas; Marilena Kampa; Eleftheria Tsentelierou; Efstathios N Stathopoulos; Andreas Tsapis; Elias Castanas
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.